Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Investing Activities (2016 - 2026)

Phibro Animal Health has reported Cash from Investing Activities over the past 13 years, most recently at -$17.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 93.4% year-over-year to -$17.2 million; the TTM value through Dec 2025 reached -$63.5 million, up 76.61%, while the annual FY2025 figure was -$288.7 million, 499.01% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$17.2 million at Phibro Animal Health, up from -$21.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $17.6 million in Q4 2021 and troughed at -$260.5 million in Q4 2024.
  • A 5-year average of -$23.5 million and a median of -$10.1 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 330.43% in 2021 and later plummeted 1715.13% in 2025.
  • Year by year, Cash from Investing Activities stood at $17.6 million in 2021, then crashed by 155.84% to -$9.8 million in 2022, then plummeted by 153.43% to -$24.9 million in 2023, then tumbled by 947.72% to -$260.5 million in 2024, then soared by 93.4% to -$17.2 million in 2025.
  • Business Quant data shows Cash from Investing Activities for PAHC at -$17.2 million in Q4 2025, -$21.0 million in Q3 2025, and -$7.0 million in Q2 2025.